MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company, announced that the Company will present at the 2023 BIO International Convention taking place in Boston, Mass. from June 5-8, 2023.
During the conference, members of the Ocugen team will host meetings with pharmaceutical executives to explore partnering and strategic opportunities for the Company’s diverse and robust clinical pipeline—specifically its ophthalmic modifier gene therapy platform, including OCU400, and the inhalation vaccines portfolio.
“Our dynamic clinical development pipeline offers the potential to address debilitating diseases that remain underserved by current therapeutic options,” said Dr. Shankar Musunuri, Chairman, Chief Executive Officer, and Co-Founder of Ocugen. “Our goal at Ocugen is to maximize the value of our pipeline for patients and shareholders, including the assessment of potential business development opportunities. BIO International provides an ideal venue for such conversations, and we look forward to actively engaging with the pharma and biotech community in attendance.”
Ocugen’s presentation details are as follows:
Event: BIO 2023 International Convention
Date: Monday, June 5, 2023
Time: 4:30 p.m. EDT
Location: Room 104B, Boston Convention and Exhibition Center
Presenter: Quan Vu, Chief Financial Officer & Chief Business Officer
Visit Ocugen at Booth #675 to learn more about the Company’s clinical programs and the potential they may hold for patients.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.